Parkinson's disease. Parkinson's disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of idiopathic Parkinson’s disease based on UK Brain Bank criteria according to neurologist Disease progression level based on Hoehn and Yahr stages of I to III Acceptable cognitive function (a score of > 24 on Montreal Cognitive Assessment Ability to read and write in Persian to complete self-reported questionnaires
Exclusion criteria
Exclusion criteria: Atypical parkinsonian syndromes Other existing neurological disorders, such as stroke Juvenile Parkinson’s Disease Impulsive-compulsive disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Participation satisfaction. Timepoint: Baseline, session 9, session 17, post-intervention (week 13), and follow-up (week 25). Method of measurement: Utrecht Scale for Evaluation of Rehabilitation-Participation Satisfaction. | — |
Secondary
| Measure | Time frame |
|---|---|
| Participation frequency and restriction. Timepoint: Baseline, session 9, session 17, post-intervention (week 13), and follow-up (week 25). Method of measurement: Utrecht Scale for Evaluation of Rehabilitation-Frequency and restriction scales.;Self-perceived performance and performance satisfaction. Timepoint: Baseline, session 9, session 17, post-intervention (week 13), and follow-up (week 25). Method of measurement: Canadian Occupational Performance Measure.;Motivation. Timepoint: Baseline, session 9, session 17, post-intervention (week 13), and follow-up (week 25). Method of measurement: Social Motivation Questionnaire.;Volition. Timepoint: Baseline, session 9, session 17, post-intervention (week 13), and follow-up (week 25). Method of measurement: Volitional Questionnaire.;Sense of agency. Timepoint: Baseline, session 9, session 17, post-intervention (week 13), and follow-up (week 25). Method of measurement: Intentional Binding Task.;Responsibility. Timepoint: Baseline, session 9, session 17, post-intervention (week 13), and follow-up (week 25). Method of measurement: Allocation of Treatment Responsibility Scale.;Physical activity. Timepoint: Baseline, session 9, session 17, post-intervention (week 13), and follow-up (week 25). Method of measurement: Phone Frequency, Intensity, Time, and Type (Phone-FITT) Questionnaire.;Community integration. Timepoint: Baseline, session 9, session 17, post-intervention (week 13), and follow-up (week 25). Method of measurement: Community Integration Questionnaire-Revised.;Activities of daily living and Instrumental activities of daily living. Timepoint: Baseline, session 9, session 17, post-intervention (week 13), and follow-up (week 25). Method of measurement: Nottingham Extended ADL Scale.;Upper extremity function. Timepoint: Baseline, session 9, session 17, post-intervention (week 13), and follow-up (week 25). Method of measurement: 9-hole peg Test.;Fatigue. Timepoint: Baseline, session 9, session 17, post-intervention (week 1 | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences